Some Aspects of the Preclinical Safety of Drugs Produced by Recombinant DNA Technology: Japanese Government Regulatory Position

dc.creator	Hayakawa, Takao	en
dc.date.accessioned	2011-07-12T18:38:51Z	en
dc.date.available	2011-07-12T18:38:51Z	en
dc.date.created	1987	en
dc.date.issued	1987	en
dc.identifier.bibliographicCitation	Progress in Clinical and Biological Research 1987; 235: 15-29	en
dc.identifier.uri	http://hdl.handle.net/10822/540454	en
dc.format	Article	en
dc.language	eng	en
dc.source	70289	en
dc.subject	DNA	en
dc.subject	Drugs	en
dc.subject	Government	en
dc.subject	Technology	en
dc.subject.classification	Drugs and Drug Industry	en
dc.subject.classification	Biohazards of Genetic Research	en
dc.title	Some Aspects of the Preclinical Safety of Drugs Produced by Recombinant DNA Technology: Japanese Government Regulatory Position	en
dc.provenance	Digital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Institute	en
dc.provenance	Digital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown University	en

Related items